Written Question

Statutory Sick Pay

Monday 4th March 2024

Asked by: Vicky Foxcroft (Labour - Lewisham, Deptford)

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, with reference to Q102 of the oral evidence given by Lorraine Jackson to the Work and Pensions Select Committee on 31 January 2024, HC 148, when the constant review of statutory sick pay began; what steps his Department is taking to conduct this review; and what sources of information are included in this review.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

As with all government policy, Statutory Sick Pay (SSP) policy is kept under review. The department through the Joint work and Health directorate, monitors feedback from correspondence and reviews evidence from a range of organisations. The rate of SSP is also reviewed each year as part of the annual uprating exercise.

The government reviewed SSP as part of both the ‘Work, health and disability green paper: improving lives’ consultation (2017) and the ‘Health is Everyone’s Business consultation’ (2019, HiEB). In response to the HiEB consultation (2021) we maintained that SSP provides an important link between the employee and employer but Ministers confirmed it was not the right time to introduce changes to the sick pay system.

---

Select Committee

First Special Report - Commons scrutiny of Secretaries of State in the House of Lords: Government Response to the Committee’s First Report

Special Report Apr. 17 2024

Committee: Procedure Committee

Found: First Special Report - Commons scrutiny of Secretaries of State in the House of Lords: Government Response

---

Written Question

Coronavirus: Vaccination

Monday 15th April 2024

Asked by: Neale Hanvey (Alba Party - Kirkcaldy and Cowdenbeath)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with the (a) Chair and (b) Chief Executive of the Medicines and Healthcare products Regulatory Agency on its statutory function to operate a system of post marketing surveillance in the UK for (i) fatal outcomes and (ii) adverse reactions in patients who have received a covid-19 vaccine.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Medicines and Healthcare products Regulatory Agency (MHRA) fulfils the requirements set out in the Human Medicines Regulation Part 11, in respect of obligations on the licensing authority to conduct surveillance of all medicinal products, including COVID-19 vaccines.

For COVID-19 vaccines, the MHRA implemented a proactive strategy, which included prospective safety data collection, and use of a range of domestic and international data sources and methodologies. For all products, events and outcomes, each data source is assessed based on its strengths and limitations, using appropriate methodologies and, where appropriate, statistical thresholds for those data. The MHRA also work closely with public health partners in reviewing the effectiveness and impact of the vaccines, to ensure the benefits continue to outweigh any possible side effects.

The MHRA keep all available evidence under review including studies, published literature, and data arising from the widespread use of COVID-19 vaccines in the United Kingdom and globally. Ministers routinely engage with officials from the MHRA on a number of issues.

---

---

Deposited Papers
Ministry of Justice

Oct. 15 2009

Source Page: The Governance of Britain. Review of the Executive Royal Prerogative Powers: Final Report. 36 p.
Document: DEP2009-2493.pdf (PDF)

Found: The Governance of Britain. Review of the Executive Royal Prerogative Powers: Final Report. 36 p.

---

Bill Documents
18 Mar 2024 - Amendment Paper
HL Bill 38-I Marshalled list for Committee
Economic Activity of Public Bodies (Overseas Matters) Bill 2022-23

Found: 8 and insert “political or moral disapproval of foreign state conduct was the primary or sole

---

Select Committee

Correspondence with Rt Hon Chris Philp MP, Minister of State for Crime, Policing and Fire at the Home Office on Firearms licensing Consultation, dated 19 April and 1 May

Correspondence May. 07 2024

Committee: Scottish Affairs Committee (Department: Scotland Office)

Found: Correspondence with Rt Hon Chris Philp MP, Minister of State for Crime, Policing and Fire at the Home

---

---

---

Select Committee

Government response to the Committee's report on Permanent secretaries: their appointment and removal (15 January 2024)

Government Response Jan. 24 2024

Committee: Constitution Committee

Found: The existing pol icies for managing the performance and conduct of permanent secretaries are fit for

---